Aging.Ai 3.0Biomarker1 paperHuman trial1LatestGeroScience·8 DecThe efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialRandomised trial in 80 peopleNicotinamide mononucleotidePaper
GeroScience·8 DecThe efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialRandomised trial in 80 peopleNicotinamide mononucleotidePaper